The prospect of hitting businesses with new testing costs as many struggle to staff back up could harden opposition to Biden’s plan, and hamper the president’s latest push to end the pandemic.
Related posts:
CDC chief warns of ‘impending doom’ as Covid cases surge
In Mississippi and New York City, leaders fight to overcome vaccine obstacles
States won’t get Johnson & Johnson vaccines next week
GOP invokes anti-abortion playbook to fight trans youth health care
NIH director: Vaccines should never be political
Calls grow for FDA to speed authorization of kid Covid-19 vaccines
Biden admin backs direct government drug price negotiations
FDA says more than 5 million electronic cigarettes must be taken off the market
‘It’s a sore spot for a lot of people’: Why officials are raising questions about Biden’s vaccine donations
Texas, Florida see uptick in Obamacare enrollment
Senate panel advances Biden’s FDA pick in 13-8 vote
Beijing to offer Olympic tickets to ‘selected’ spectators amid pandemic
